Increased rectal nitric oxide in coeliac disease after local challenge with gluten

被引:16
作者
Herulf, M [1 ]
Blomquist, L
Ljung, T
Weitzberg, E
Lundberg, JON
机构
[1] Karolinska Inst, Div Pharmacol, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden
[2] Karolinska Hosp, Dept Gastroenterol & Hepatol, S-10401 Stockholm, Sweden
[3] Karolinska Hosp, Dept Anaesthesiol & Intens Care, S-10401 Stockholm, Sweden
关键词
colon; inducible nitric oxide synthase; non-tropical spine;
D O I
10.1080/003655201750065924
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Coeliac disease is an inflammatory disorder characterized by reversible atrophy of small intestinal villi following the ingestion of gluten. Earlier studies indicate that the inflammatory response to gluten may occur also very distally in the gastrointestinal tract. The aim of this study was to evaluate whether rectal challenge with gluten would trigger an increased local production of the gas nitric oxide (NO), a novel marker of intestinal inflammation. Methods: Rectal challenge with partially digested gluten was performed in 20 patients with treated coeliac disease and in 13 healthy controls. Luminal levels of NO were measured in the rectum at 0, 8 and 24 h using a chemiluminescence technique. Results: In patients with coeliac disease mean rectal NO increased from 235 +/- 90 parts per billion (ppb) at 0 h to 4965 +/- 1653 ppb at 24 h (P < 0.005). In the control group there was no significant increase. One control subject responded with high NO levels at 24 h and the same individual tested positive for anti-endomysium IgA antibodies. Subsequent duodenal biopsing showed substantial villusatrophy. Conclusions: Rectal challenge with gluten results in increased luminal levels of NO in a group of patients with treated coeliac disease. Further studies are needed to evaluate the role of NO in coeliac disease and the potential usefulness of rectal NO measurements in aiding diagnosis of this intestinal disorder.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 31 条
[1]  
ALVING K, 1993, EUR RESPIR J, V6, P1368
[2]   MEASUREMENT OF NITRIC-OXIDE IN BIOLOGICAL MODELS [J].
ARCHER, S .
FASEB JOURNAL, 1993, 7 (02) :349-360
[3]  
Beckett CG, 1998, EUR J GASTROEN HEPAT, V10, P641
[4]  
Everts B, 1999, EUR J CLIN INVEST, V29, P692
[5]   Fortnightly review - Coeliac disease [J].
Feighery, C .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7204) :236-239
[6]   Pre-and post-treatment serum levels of cytokines IL-1β, IL-6, and IL-1 receptor antagonist in celiac disease.: Are they related to the associated osteopenia? [J].
Fornari, MC ;
Pedreira, S ;
Niveloni, S ;
González, D ;
Diez, RA ;
Vázquez, H ;
Mazure, R ;
Sugai, E ;
Smecuol, E ;
Boerr, L ;
Mauriño, E ;
Bai, JC .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) :413-418
[7]  
FRAZER AC, 1959, LANCET, V2, P252
[8]   Increased nitric oxide in infective gastroenteritis [J].
Herulf, M ;
Svenungsson, B ;
Lagergren, Å ;
Ljung, T ;
Morcos, E ;
Wiklund, NP ;
Lundberg, JON ;
Weitzberg, E .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :542-545
[9]  
Herulf M, 1998, SCAND J GASTROENTERO, V33, P164
[10]   Coeliac disease in primary care: case finding study [J].
Hin, H ;
Bird, G ;
Fisher, P ;
Mahy, N ;
Jewell, D .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7177) :164-167